These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 29604336)

  • 21. Hymenoptera Allergy and Mast Cell Activation Syndromes.
    Bonadonna P; Bonifacio M; Lombardo C; Zanotti R
    Curr Allergy Asthma Rep; 2016 Jan; 16(1):5. PubMed ID: 26714690
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Symptoms of mast cell activation: The patient perspective.
    Jennings SV; Slee VM; Finnerty CC; Hempstead JB; Bowman AS
    Ann Allergy Asthma Immunol; 2021 Oct; 127(4):407-409. PubMed ID: 34271184
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical and functional differences among patients with idiopathic anaphylaxis.
    Tejedor Alonso MA; Sastre Dominguez J; Sánchez-Hernández JJ; PérezFrances C; Hoz de la Caballer B
    J Investig Allergol Clin Immunol; 2004; 14(3):177-86. PubMed ID: 15552710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment strategies in mastocytosis.
    Siebenhaar F; Akin C; Bindslev-Jensen C; Maurer M; Broesby-Olsen S
    Immunol Allergy Clin North Am; 2014 May; 34(2):433-47. PubMed ID: 24745685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urticaria, Angioedema, and Anaphylaxis.
    Pier J; Bingemann TA
    Pediatr Rev; 2020 Jun; 41(6):283-292. PubMed ID: 32482691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical response to omalizumab in patients with hereditary α-tryptasemia.
    Mendoza Alvarez LB; Barker R; Nelson C; DiMaggio T; Stone KD; Milner JD; Rosenthal JA; Petroni DH; Glover SC; Lyons JJ
    Ann Allergy Asthma Immunol; 2020 Jan; 124(1):99-100.e1. PubMed ID: 31605754
    [No Abstract]   [Full Text] [Related]  

  • 27. Urticaria and urticarial vasculitis.
    Guha B; Youngberg G; Krishnaswamy G
    Compr Ther; 2003; 29(2-3):146-56. PubMed ID: 14606344
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anaphylactic reaction to white-faced hornet sting and elevated baseline (asymptomatic) serum tryptase.
    Lieberman P; Schwartz LB
    J Allergy Clin Immunol Pract; 2013; 1(3):315. PubMed ID: 24565497
    [No Abstract]   [Full Text] [Related]  

  • 29. Drug allergy in mastocytosis.
    Bonadonna P; Lombardo C
    Immunol Allergy Clin North Am; 2014 May; 34(2):397-405. PubMed ID: 24745682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urticaria & angioedema: a rational approach to diagnosis and therapy.
    Dreyfus DH
    Skin Therapy Lett; 2013 Jan; 18(1):4-9. PubMed ID: 23474656
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mast Cell Disorders In Drug Hypersensitivity.
    Bonadonna P; Bonifacio M; Zanotti R
    Curr Pharm Des; 2016; 22(45):6862-6869. PubMed ID: 27779084
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety of a 2-day ultrarush immunotherapy in vespid allergic patients: Focus on elevated serum tryptase.
    Bilò MB; Corsi A; Agolini S; Tontini C; Antonicelli L
    Ann Allergy Asthma Immunol; 2018 Jul; 121(1):130-132. PubMed ID: 29577980
    [No Abstract]   [Full Text] [Related]  

  • 33. Clonal mast cell disorders in patients with severe Hymenoptera venom allergy and normal serum tryptase levels.
    Zanotti R; Lombardo C; Passalacqua G; Caimmi C; Bonifacio M; De Matteis G; Perbellini O; Rossini M; Schena D; Busa M; Marcotulli MC; Bilò MB; Franchini M; Marchi G; Simioni L; Bonadonna P
    J Allergy Clin Immunol; 2015 Jul; 136(1):135-9. PubMed ID: 25605272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel model of IgE-mediated passive pulmonary anaphylaxis in rats.
    Wex E; Thaler E; Blum S; Lamb D
    PLoS One; 2014; 9(12):e116166. PubMed ID: 25541997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urinary N-methyl histamine levels relate to the presence of angioedema and decrease with the duration of chronic urticaria.
    Patel B; Divekar R
    J Allergy Clin Immunol Pract; 2017; 5(1):201-203. PubMed ID: 27838330
    [No Abstract]   [Full Text] [Related]  

  • 36. Pediatric Expression of Mast Cell Activation Disorders.
    Broesby-Olsen S; Carter M; Kjaer HF; Mortz CG; Møller MB; Kristensen TK; Bindslev-Jensen C; Agertoft L
    Immunol Allergy Clin North Am; 2018 Aug; 38(3):365-377. PubMed ID: 30007457
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of omalizumab on angioedema in H1 -antihistamine-resistant chronic spontaneous urticaria patients: results from X-ACT, a randomized controlled trial.
    Staubach P; Metz M; Chapman-Rothe N; Sieder C; Bräutigam M; Canvin J; Maurer M
    Allergy; 2016 Aug; 71(8):1135-44. PubMed ID: 27010957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mast Cell Mediators of Significance in Clinical Practice in Mastocytosis.
    Butterfield JH; Ravi A; Pongdee T
    Immunol Allergy Clin North Am; 2018 Aug; 38(3):397-410. PubMed ID: 30007459
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A case of neuropathic pain in monoclonal mast cell activation syndrome.
    Bay JL; Sedarsky KE; Petersen MM
    Ann Allergy Asthma Immunol; 2018 May; 120(5):543-544. PubMed ID: 29481890
    [No Abstract]   [Full Text] [Related]  

  • 40. [Diagnosis and treatment of urticaria and angioedema].
    Panaszek B
    Pol Merkur Lekarski; 2003 Jun; 14(84):553-6. PubMed ID: 14524269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.